Ellington Management Group’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Ellington Management Group’s Portfolio INFI Stock Details INFI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-21,664	Closed	-$183K	–	870
2015 Q3	$183K	Sell	21,664 -5,036	-19%	-$46.5K	0.05%	601
2015 Q2	$292K	Buy	+26,700	New	+$343K	0.07%	438
2015 Q1	–	Sell	-25,500	Closed	-$431K	–	856
2014 Q4	$431K	Buy	+25,500	New	+$371K	0.14%	236
2013 Q3	–	Sell	-38,700	Closed	-$627K	–	1003
2013 Q2	$627K	Buy	+38,700	New	+$1.2M	0.12%	225

Other funds holding INFI

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ellington Management Group's INFI Position: Q4 2015 in Review

Ellington Management Group sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2015, closing a stake of 21,664 shares — an estimated $183K sold.

Ellington Management Group first reported a position in INFI in Q2 2013 and held it in 4 quarters. The position peaked at $627K in Q2 2013. 115 funds tracked by Wall St. Rank hold INFI as of Q4 2015.

Ellington Management Group reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
Ellington Management Group sold 21,664 Infinity Pharmaceuticals, Inc. shares in Q4 2015, an estimated $183K.
Ellington Management Group first reported a position in Infinity Pharmaceuticals, Inc. in Q2 2013 and held it in 4 quarters.
Ellington Management Group's Infinity Pharmaceuticals, Inc. position peaked at $627K in Q2 2013.
115 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2015.

Based on Ellington Management Group's 13F filing for Q4 2015, filed 16 Feb 2016.